Previous Article | Next Article 
Infection and Immunity, March 1999, p. 1180-1186, Vol. 67, No. 3
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Activation of Murine Macrophages by Lipoprotein and
Lipooligosaccharide of Treponema denticola
Graciela
Rosen,1,*
Michael N.
Sela,1
Ronit
Naor,1
Amal
Halabi,2
Vivian
Barak,3 and
Lior
Shapira2
Departments of Oral
Biology1 and
Periodontology,2 Hebrew
University-Hadassah Faculty of Dental Medicine, and
Department of Oncology, Hadassah Medical
Center,3 Jerusalem, Israel
Received 10 July 1998/Returned for modification 8 October
1998/Accepted 8 December 1998
 |
ABSTRACT |
We have recently demonstrated that the periodontopathogenic oral
spirochete Treponema denticola possesses
membrane-associated lipoproteins in addition to lipooligosaccharide
(LOS). The aim of the present study was to test the potential of these
oral spirochetal components to induce the production of inflammatory
mediators by human macrophages, which in turn may stimulate tissue
breakdown as observed in periodontal diseases. An enriched lipoprotein
fraction (dLPP) from T. denticola ATCC 35404 obtained upon
extraction of the treponemes with Triton X-114 was found to stimulate
the production of nitric oxide (NO), tumor necrosis factor alpha
(TNF-
), and interleukin-1 (IL-1) by mouse macrophages in a
dose-dependent manner. Induction of NO by dLPP was at 25% of the
levels obtained by Salmonella typhosa lipopolysaccharide
(LPS) at similar concentrations, while IL-1 was produced at similar
levels by both inducers. dLPP-mediated macrophage activation was
unaffected by amounts of polymyxin B that neutralized the induction
produced by S. typhosa LPS. dLPP also induced NO and
TNF-
secretion from macrophages isolated from endotoxin-unresponsive
C3H/HeJ mice to an extent similar to the stimulation produced in
endotoxin-responsive mice. Purified T. denticola LOS also
produced a concentration-dependent activation of NO and TNF-
in
LPS-responsive and -nonresponsive mouse macrophages. However,
macrophage activation by LOS was inhibited by polymyxin B. These
results suggest that T. denticola lipoproteins and LOS may
play a role in the inflammatory processes that characterize periodontal diseases.
 |
INTRODUCTION |
Periodontal pathogens possess
virulent factors that are able to induce the synthesis of inflammatory
mediators by host cells (9). Tumor necrosis factor alpha
(TNF-
) and interleukin-1 (IL-1) were found to be elevated in tissues
involved in periodontal diseases and have been suggested to play a part
in the accompanying tissue destruction (17, 18, 22, 23).
Wahl et al. also reported increased NO levels in human inflamed
periodontal tissues compared to those of uninflamed gingiva
(38).
Treponema denticola, the oral spirochete associated with
periodontal diseases (15, 32), was shown to possess various
properties which enable it to damage periodontal tissues, e.g.,
motility, high proteolytic activity (12, 13, 28), adherence
to epithelial cells, and cytotoxicity (36), as well as
factors which may inhibit host cell functions (30). In
addition, the proteases of this bacterium can cleave the IL-1
precursor with the generation of biologically active fragments
(3). We have recently showed that T. denticola
possesses membrane-associated lipoproteins and a lipooligosaccharide
(LOS) (31). An enriched delipidated lipoprotein fraction
from T. denticola was shown by us to trigger the production of oxygen radicals and induced lysozyme release from human
polymorphonuclear neutrophils (31).
Lipoproteins from other spirochetes, such as Treponema
pallidum and Borrelia burgdorferi, the etiological
agents of syphilis and Lyme disease, have been isolated, and their
roles as inflammatory mediators were recently studied (11,
25). It has been shown that spirochetal lipoproteins, covalently
modified with fatty acids similarly to the Escherichia coli
murine lipoprotein, may act as major immunogens (4) as well
as potent in vitro activators of monocytes/macrophages (25),
B lymphocytes, and endothelial cells (11, 27). Synthetic
lipopeptides corresponding to the lipoproteins' N-terminal domains
were found to be responsible for the monocyte/macrophage activation
(25). Furthermore, Norgard et al. (20) reported
that both lipoproteins and their lipopeptide analogues induced dermal
inflammatory reactions in vivo similar to those observed upon injection
of whole spirochetes.
Oral spirochetes are normally found in low numbers in the gingival
sulcus in direct contact with the epithelium. Their numbers increase
drastically in diseased sites, where the pocket epithelial layer loses
its attachment to the teeth and is characterized by microulcerations,
irregular ridges, and discontinuous basal lamina (22). At
this point, bacterial products may have deleterious effects on the
underlying connective tissue (26) by activating host immune
cells, which produce and release mediators that stimulate connective
tissue breakdown. Diseased periodontal sites are characterized by a
significant elevation in the number of pathogenic bacteria, including
spirochetes, in the presence of dense inflammatory infiltrates. The aim
of the present study was to investigate the capacity of T. denticola enriched lipoprotein fraction and LOS to activate secretory responses of macrophages.
 |
MATERIALS AND METHODS |
Bacteria.
T. denticola ATCC 35404 was obtained from
the American Type Culture Collection, Rockville, Md., and cultured as
described previously (28).
Preparation of detergent phase proteins.
Extraction and
phase separation with Triton X-114 was performed as described
previously (31). The detergent phase proteins were
delipidated by two washes of hexane-isopropanol (3:2 [vol/vol]) (24) and designated dLPP (delipidated lipoprotein). This
solvent mixture was preferred to chloroform-methanol delipidation as it rendered homogeneous protein suspensions after resuspension of the
lipoproteins in aqueous media. Where stated, dLPP was treated overnight
at 37°C with proteinase K (Sigma) (1 µg of proteinase K/1.5 µg of
dLPP) after the fraction was boiled for 10 min at 100°C.
Extraction and purification of LOS.
Extraction and
purification of LOS was performed as described before (31)
with the following modification. After submitting the methanol
precipitate to lyophylization, we resuspended it in phosphate-buffered
saline (PBS), boiled it for 10 min, and further treated it with
proteinase K for 24 h at 37°C to hydrolyze any contaminating
protein. This procedure was repeated twice. The extract was then
submitted to hydrophobic chromatography as described previously
(31). Biosynthetic labeling of the spirochetes and sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was
performed as described previously (31). After being labeled,
LOS was purified as described above.
Care was taken to prevent contamination of the T. denticola
components with endotoxin throughout the isolation procedures. Endotoxin-free water (Biological Industries) was used for the preparation of all media and buffers.
Preparation of mouse inflammatory macrophages.
A 1.5-ml
quantity of 3% thioglycolate broth (Difco, Detroit, Mich.) was
injected intraperitoneally into female mice 7 to 8 weeks of age. Four
days after injection, the mice were sacrificed by cervical dislocation,
and the peritoneum was washed with PBS. Macrophages were collected by
aspiration of the PBS from the peritoneal cavity, washed twice, and
counted with a hemocytometer. Cell viability was verified by the trypan
blue exclusion technique and was found to be >95% in all experiments.
The macrophages were suspended in RPMI 1640 medium (Biological
Industries, Beit Ha-Emek, Israel) containing 100 U of penicillin/ml,
100 µg of streptomycin/ml, 2 mM L-glutamine, and 5%
fetal calf serum. The cells were plated in 24-well tissue culture
plates (106 per well) and incubated for 60 min (37°C; 5%
CO2). Nonadherent cells were removed by aspiration, and the
remaining adherent cells were washed three times with PBS prior to
being used in the subsequent experiments. More than 95% of the cells
were nonspecific esterase positive.
NO2
accumulation.
NO2
accumulation was used as an indicator of
NO production in the medium and was assayed by Gries reagent
(5). Briefly, 100 µl of Gries reagent (1%
sulfanilamide-0.1% naphthylethylene diamine dihydrochloride-2.5%
H3PO4 [all from Sigma]) was added to 100 µl
of each supernatant in triplicate wells of 96-well plates. The plates
were read in a Vmax microplate reader (Molecular Devices, Palo Alto,
Calif.) at 550 nm against a standard curve of NaNO2 (Sigma)
in culture medium.
TNF-
measurement.
Mouse TNF-
was measured by
enzyme-linked immunosorbent assay (ELISA) with an antibody pair from
Pharmingen (San Diego, Calif.). ELISA plates (96-well) (Maxisorp; Nunc,
Naperville, Ill.) were coated with anti-TNF-
monoclonal antibody in
a coating buffer (carbonate-bicarbonate buffer, pH 9.6) followed by
overnight incubation at 4°C. The wells were blocked overnight (4°C)
with 3% bovine serum albumin in coating buffer and washed, and samples
in duplicate were added and incubated overnight (4°C). A rat
anti-TNF-
biotinylated antibody was added, followed by
streptavidin-horseradish peroxidase conjugate (Jackson ImmunoResearch
Laboratories, West Grove, Pa.). o-Phenylenediamine was used
as the substrate. The reaction was terminated by the addition of 4 N
sulfuric acid, and the optical density was read in a Vmax microplate
reader at 490 to 650 nm.
IL-1 bioassay.
The assay used for measurement of IL-1
bioactivity was the modified lymphocyte activating factor assay as
described earlier (2). Briefly, thymocytes from 1-month-old
C3H/HeJ mice were dispersed into single-cell suspensions in complete
RPMI. 2-Mercaptoethanol (50 µM), phytohemagglutinin (1 µg/ml final
concentration) and 4 U of recombinant human IL-1
/ml (final
concentration) were added to each well to establish a positive
proliferation. The cells were plated at 5 × 106 well
in 100 µl. The cultures were incubated at 37°C in 5%
CO2 for 72 h with the addition of 1 µCi of
well-tritiated thymidine (5 mCi/mmol) (ICN) for the last 12 h and
harvested onto glass fiber strips (PHD cell harvester, Cambridge,
Mass.). Scintillation fluid was added, and the vials were counted in
quadruplicate in a beta counter.
Endotoxin analysis.
dLPP and the purified LOS were assayed
for the presence of endotoxin activity by the Limulus
amoebocyte lysate assay (kinetic turbidimetric method, performed by
Biological Industries). Endotoxin activities of 0.05 and 0.36 ng/µg
were found for dLPP and LOS, respectively.
Data analysis.
All experiments were carried out three to
five times, except for IL-1 determination, which was carried out in two
independent experiments. Each condition was maintained in four to six
replicate wells of cell culture. Statistical significance between
treatments was calculated by one-way analysis of variance. When the
results showed a significant difference between groups, the
significance was calculated by the Bonferroni t test. The
level of significance was determined to be a P value of
<0.05.
 |
RESULTS |
dLPP of T. denticola ATCC 35404 induced the production
of NO in mouse macrophages in a concentration-dependent manner (Fig. 1). Maximal induction by dLPP was
obtained at 5 µg/ml, a concentration which reached saturation.
Salmonella typhosa lipopolysaccharide (LPS) was used as a
positive control through all the experiments at a concentration of 1 µg/ml. Induction of NO by dLPP reached 25% of the levels obtained by
LPS at similar concentrations. In order to ascertain that macrophage
activation by dLPP was not due to contaminating endotoxin, macrophages
were incubated with either LPS or dLPP in the presence of polymyxin B,
which is known to form a stable complex with the lipid A region and
neutralizes LPS activity (16). While NO production induced
by S. typhosa LPS was reduced by 90% in the presence of
polymyxin B, no effect on NO induction produced by T. denticola dLPP was observed (Fig. 1).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
Stimulation of nitric oxide production by dLPP.
Peritoneal mouse macrophages were incubated with increasing
concentrations of dLPP in the presence or absence of polymyxin B (10 µg/ml). S. typhosa LPS (1 µg/ml) was used as a positive
control. The supernatants were removed after 24 h and assayed for
the presence of nitric oxide. The results are expressed as the
mean ± standard deviation of four to six culture wells. *,
P < 0.05 versus no dLPP; **, P < 0.05 versus LPS plus polymyxin B.
|
|
Induction of NO by LPS and dLPP was also examined in macrophages from
LPS-nonresponsive C3H/HeJ mice (Fig. 2).
These macrophages produced very low NO levels when incubated with 1 µg of LPS/ml, and the values were not different from the basal NO
secretion. On the other hand, stimulation of C3H/HeJ macrophages with
T. denticola dLPP (5 µg/ml) induced a sixfold enhancement
of NO secretion and was not affected by the addition of polymyxin B.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 2.
Stimulation of nitric oxide production by C3H/HeJ
(LPS-nonresponsive) mouse macrophages. The cells were incubated with
dLPP (5 µg/ml) in the presence or absence of polymyxin B (10 mg/ml).
S. typhosa LPS (1 µg/ml) was used as a control. The
supernatants were removed after 24 h and assayed for the presence
of nitric oxide. The results are expressed as the mean + standard
deviation of four to six culture wells. *, significantly different
from cells stimulated by LPS (P < 0.05). No
significant difference was observed between stimulation with dLPP and
stimulation with dLPP plus polymyxin B.
|
|
The effect of T. denticola dLPP on the production of IL-1
and TNF-
by mouse macrophages was also studied. LPS and dLPP at concentrations of 1 µg/ml induced the same level of secretion of IL-1
(Fig. 3).

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 3.
Stimulation of IL-1 production by peritoneal mouse
macrophages incubated with dLPP (1 and 5 µg per ml). S. typhosa LPS (1 µg/ml) and recombinant IL-1 (rIL-1) (1 ng/ml)
were used as controls. The supernatants were removed after 24 h
and assayed for the activity of IL-1. The results are expressed as the
mean + standard deviation of four to six culture wells. A
significant difference was observed between dLPP stimulation and
control cells.
|
|
T. denticola dLPP induced the production of TNF-
in both
LPS-responsive (Fig. 4, left panel) and
LPS-nonresponsive (C3H/HeJ) (Fig. 4, right panel) macrophages in a
concentration-dependent manner. The dLPP-mediated induction of both
cytokines was not affected by the addition of polymyxin B (Fig. 3 and
data not shown).

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 4.
Stimulation of TNF- production by responsive (left)
and nonresponsive (right) mouse macrophages by increasing
concentrations of dLPP. Peritoneal mouse macrophages were incubated
with the indicated dLPP concentrations. The supernatants were removed
after 24 h and assayed for the presence of TNF- . The results
are expressed as the mean + standard deviation of four to six
culture wells. *, statistically significant differences from control
cells with no stimulation (P < 0.05).
|
|
In order to find out whether structurally intact proteins contribute to
the dLPP-induced macrophage activation, dLPP was submitted to
degradation by proteinase K. As shown in Fig.
5, proteolytic degradation of dLPP prior
to stimulation of the macrophages decreased the production of NO by
50%.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 5.
Stimulation of nitric oxide production by dLPP (5 µg/ml) before ( ) and after (+) degradation with proteinase K (PK).
S. typhosa LPS (1 µg/ml) was used as a positive control.
The results are expressed as the mean + standard deviation of four
to six culture wells. *, statistically significant difference from
control cells; #, significantly lower than dLPP without PK.
|
|
We have previously shown that T. denticola possesses an LOS
molecule that can be extracted from the bacterium by the classical phenol-water method, followed by intensive proteolysis to degrade contaminating proteins, and purified by hydrophobic chromatography. SDS-PAGE of the purified LOS is shown in Fig.
6. The ability of the purified LOS to
activate macrophages from LPS-responsive and LPS-nonresponsive mouse
macrophages was further investigated. The LOS molecule induced the
production of NO (Fig. 7, left panel) and
TNF-
(Fig. 7, right panel) in a dose-dependent manner, but in
contrast to dLPP, the LOS-mediated induction decreased by 80% in the
presence of polymyxin B. Furthermore, LOS was able to induce TNF-
secretion from LPS-nonresponsive macrophages (Fig.
8).

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 6.
SDS-PAGE of the purified LOS of T. denticola
ATCC 35404. Lane 1, silver stain; lane 2, autoradiography of the
cis[9-3H]octadecanoic acid-labeled LOS.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 7.
Stimulation of nitric oxide (left) and TNF- (right)
production by mouse macrophages incubated with increasing amounts of
LOS in the presence or absence of polymyxin B (10 µg/ml). The results
are expressed as the mean ± standard deviation of four to six
culture wells. *, significantly higher than control cells; #,
significantly lower than cells stimulated with LOS alone.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 8.
Stimulation of TNF- production by C3H/HeJ
(LPS-nonresponsive) macrophages by LOS (5 µg/ml). S. typhosa LPS (1 µg/ml) was used as a control. The supernatants
were removed after 24 h and assayed for the presence of nitric
oxide. The results are expressed as the mean + standard deviation
of four to six culture wells. *, significantly different from control
cells and LPS-stimulated cells.
|
|
The kinetics of macrophage activation by dLPP and LOS were compared by
measuring the NO induction of both stimulators after 24 and 48 h.
Figure 9 shows kinetics of activation for
the LOS different than that observed for dLPP. Maximal activation of NO by LOS was obtained after 24 h and then leveled off, while dLPP caused increased NO production throughout 48 h. S. typhosa LPS was used as a positive control and showed kinetics of
activation similar to that of the T. denticola dLPP.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 9.
Kinetics of nitric oxide production by mouse macrophages
stimulated with dLPP, LOS, and S. typhosa LPS. Peritoneal
mouse macrophages were incubated with either dLPP (5 µg/ml), LOS (5 µg/ml), or S. typhosa LPS (1 µg/ml) for the indicated
time intervals. The supernatants were removed and assayed for the
presence of nitric oxide. The results are expressed as the mean ± standard deviation of four to six culture wells. *, significantly
different from the LOS and dLPP group. The last two groups were not
significantly different. #, All three groups were significantly
different from each other.
|
|
 |
DISCUSSION |
Recent work in our laboratory has shown that T. denticola possesses membrane-associated lipoproteins and LOS
(31). We also showed that an enriched lipoprotein fraction
(dLPP) caused an enhanced luminol-dependent chemiluminescence effect
and induced lyzozyme release by human polymorphonuclear leukocytes
(31).
The present results demonstrate that dLPP and the purified LOS of
T. denticola 35404 are able to induce the synthesis of NO, IL-1, and TNF-
by murine macrophages. As Triton X-114 detergent phase extracts contain protein and nonprotein amphipathic molecules, it
was important to determine the extent of macrophage activation by dLPP
and LOS and to exclude the possibility that contaminating exogenous
endotoxin was responsible for the macrophage activation. dLPP-mediated
activation of mouse macrophages was unaffected by levels of polymyxin B
that were found to neutralize the activity of LPS isolated from
S. typhosa, as measured by the secretion of TNF-
, IL-1,
and NO. The lack of LPS involvement was also substantiated by the
observation that dLPP induced NO and TNF-
production in LPS-unresponsive C3H/HeJ mice while S. typhosa LPS (1 µg/ml) had no effect on these cells. The Limulus
amoebocyte lysate assay indicated the presence of very low endotoxin
activity in the dLPP fraction (0.05 ng/µg of dLPP), which may be due
to the presence of the T. denticola LOS in this fraction. It
is worth noting that concentrations of bacterial endotoxin over 0.1 µg/ml are needed to induce detectable NO secretion by macrophages
(41); therefore, the endotoxin levels found in dLPP are too
low to explain the considerable amounts of NO and cytokines secreted
following activation by dLPP.
dLPP appears to differ from purified S. typhosa LPS in its
relative ability to induce IL-1, TNF-
, and NO. dLPP was consistently more potent in inducing IL-1 than in inducing NO and TNF-
(Fig. 1,
3, and 4). NO production was induced by proteinase K-digested treponemal dLPP. These findings suggest that N-terminal lipopeptides may constitute the biologically functional portions of the molecules, similar to the murine lipoprotein of E. coli as well as to
the spirochetal lipoproteins of T. pallidum and B. burgdorferi. Interestingly, proteinase K-degraded dLPP was unable
to directly stimulate human polymorphonuclear leukocytes
(31), in contrast to the undigested counterpart, suggesting
that different molecules in dLPP are responsible for the
polymorphonuclear leukocyte and macrophage stimulation.
T. denticola possesses an LOS of approximately 14 to 21 kDa,
which runs as a broad band in SDS-PAGE. This LOS was purified from
strain ATCC 35404 (31), but it is also present in T. denticola ATCC 33520 and the clinical isolate GM-1 (unpublished
observations). Yotis et al. (40) have also isolated LOS from
various strains of T. denticola, including ATCC 35404, using
a similar extraction methodology. Although the chemical structure of
this molecule was not elucidated, its chemical composition resembled
some characteristics of LPS (40). On the other hand, Schultz
et al. (29) have recently proposed that T. denticola LOS is a new type of outer membrane lipid. Their
chemical analysis places this molecule chemically close to the
lipoteichoic acids of gram-positive bacteria, while its biophysical
membrane behavior is similar to that of the LPSs of gram-negative
bacteria. It was therefore of interest to investigate its ability to
activate macrophages and to assess its contribution to the
dLPP-mediated macrophage activation due to its presence in the dLPP
fraction. LOS stimulated the activation of NO and TNF-
in
LPS-responsive and -nonresponsive mouse macrophages. Macrophage
activation by LOS, similarly to LPS activation, was neutralized by
polymyxin B, but in contrast to LPS, LOS was found to stimulate
macrophages from LPS-nonresponsive mice. It is unlikely that activation
of C3H/HeJ macrophages is due to contaminating proteins, as the LOS was
submitted to repeated boiling and protease degradation before the
chromatographic removal of the proteins.
On the other hand, although LOS is present in the dLPP fraction, its
contribution to the overall dLPP-mediated macrophage activation does
not seem to be significant. Silver-stained SDS-PAGE of dLPP
(31) and densitometric analysis (not shown) showed that the
LOS does not represent more than 5 to 6% of the total stain, and thus
its concentration in dLPP concentrations effective for activation is
very low. dLPP-mediated macrophage activation was not inhibited by
polymyxin B, while LOS activation was significantly decreased by it.
Furthermore, LOS and dLPP showed different activation kinetics (Fig.
9). Thus, it seems that T. denticola may induce macrophage
activation by at least two types of molecules, LOS and a different
component(s) of dLPP, probably lipoproteins.
Gram-negative bacteria and their products are considered to be the
primary causes of periodontal disease (33). However, data
accumulated over the last decade emphasize the important role of the
host response, not only in protecting the tissues from the bacterial
burden but also in the process of periodontal destruction
(37). Bacterial products have the ability to stimulate host
cells to secrete a wide variety of proinflammatory mediators, which
have numerous functions, some of which result in soft tissue and bone
destruction (17, 18, 23). Proinflammatory cytokines, such as
TNF-
and IL-1
, are known inducers of bone resorption (17). These cytokines have been found in high levels in the gingival tissues and gingival crevicular fluids of patients with periodontal disease, and their presence has also been correlated with
active bursts of periodontal disease activity (10, 21, 34,
35). In addition, antibodies to TNF-
and IL-1
were recently found to block experimental periodontal disease in a primate model (1). Taken together, the evidence suggests that these two
proinflammatory cytokines are important mediators in the progression of
periodontal destruction.
NO may be produced in large amounts and over long periods when
inflammatory stimuli induce the nitric oxide synthetase of various host
cells (8, 19). NO is an important mediator in the killing of
intracellular parasites by macrophages (6, 7), and it is
also involved in inflammatory conditions, such as autoimmune disorders
(39) and streptococcal cell wall arthritis (14). In the latter condition, NO seems to contribute to bone erosion and
cartilage destruction (14).
It has been reported that inflamed periodontal tissues generate
increased nitrite levels compared to uninflamed gingival tissues (38). LPS from gram-negative periodontopathogenic bacteria
as well as dLPP or LOS from oral spirochetes may contribute to the enhanced NO levels in the periodontal tissues. Nevertheless, no data
are available on the possible role of NO in the elimination of
periodontal bacteria or its contribution to the injury accompanying periodontitis.
Using monoclonal antibodies against T. denticola, which is
part of the anaerobic flora found in periodontal pockets, Simonson et
al. (32) established quantitative evidence for a positive relationship between the presence of this oral spirochete and severe
periodontitis. These diseases are chronic inflammatory processes that
ultimately lead to a continuous alveolar bone and periodontal
connective tissue destruction. The data presented in this study show
that oral treponemal lipoproteins and LOS may contribute to the chronic
inflammatory periodontal process. T. denticola may attach to
epithelial cells and induce loss of cell contacts and increased
epithelial permeability (36). These effects may facilitate
the access of spirochetal molecules, some of which are associated with
outer sheath membrane blebs (28), to connective tissue
macrophages and induce their activation.
 |
ACKNOWLEDGMENT |
This study was supported by the Chief Scientist of the
Israeli Ministry of Health (grants to M.N.S., G.R., and L.S.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Oral Biology, Faculty of Dental Medicine, the Hebrew University, P.O. Box 12272, Jerusalem 91120, Israel. Phone: 972-2-6758585. Fax: 972-2-6784010. E-mail: grosen{at}pob.huji.ac.il.
Editor:
J. R. McGhee
 |
REFERENCES |
| 1.
|
Assuma, R.,
T. Oates,
D. Cochran,
S. Amar, and D. Graves.
1997.
IL-1/TNF account for most of the inflammatory response in experimental periodontitis. IADR abstract 1298.
J. Dent. Res.
76:176.
|
| 2.
|
Barak, V.,
D. Peritt,
I. Flechner,
P. Yanai,
T. Halperin,
A. J. Treves, and C. A. Dinarello.
1991.
The specific IL-1 inhibitor from the human M20 cell line is distinct from the IL-1 receptor antagonist.
Lymphokine Cytokine Res.
10:437-442[Medline].
|
| 3.
|
Beausejour, A.,
N. Deslauriers, and D. Grenier.
1997.
Activation of the interleukin-1b precursor by Treponema denticola: a potential role in chronic inflammatory periodontal diseases.
Infect. Immun.
65:3199-3202[Abstract].
|
| 4.
|
Brandt, M. E. B.,
S. Ridley,
J. D. Radolf, and M. V. Norgard.
1990.
Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins.
Infect. Immun.
58:983-991[Abstract/Free Full Text].
|
| 5.
|
Ding, A. H.,
C. F. Nathan, and D. J. Stuehr.
1988.
Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages.
J. Immunol.
141:2407-2412[Abstract].
|
| 6.
|
Evans, T. G.,
L. Thai,
D. L. Granger, and J. B. Hibbs, Jr.
1993.
Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis.
J. Immunol.
151:907-915[Abstract].
|
| 7.
|
Green, S. J.,
M. S. Meltzer,
J. B. Hibbs, Jr., and C. A. Nacy.
1990.
Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine dependent killing mechanism.
Immunology
144:278-283.
|
| 8.
|
Hibbs, J. B., Jr.,
R. R. Taintor,
Z. Vavrin, and E. M. Rachlin.
1988.
Nitric oxide: a cytotoxic activated macrophage effector molecule.
Biochem. Biophys. Res. Commun.
157:87-94[Medline].
|
| 9.
|
Holt, S. C., and T. E. Bramanti.
1991.
Factors in virulence expression and their role in periodontal disease pathogenesis.
Crit. Rev. Biol. Med.
2:177-281.
|
| 10.
|
Honig, J.,
C. Rordorf-Adam,
C. Siegmund,
W. Wiedermann, and F. Erard.
1989.
Increased interleukin-1 beta concentration in gingival tissue from periodontitis patients.
J. Periodontal Res.
24:362-367[Medline].
|
| 11.
|
Ma, Y., and J. J. Weis.
1993.
Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties.
Infect. Immun.
61:3843-3853[Abstract/Free Full Text].
|
| 12.
|
Makinen, K. K.,
P. L. Makinen, and S. A. Syed.
1992.
Purification and substrate specificity of an endopeptidase from the human oral spirochete Treponema denticola ATCC 35405, active on furacryloyl-Leu-Gly-Pro-Ala and bradykinin.
J. Biol. Chem.
267:14285-14293[Abstract/Free Full Text].
|
| 13.
|
Makinen, K. K.,
P. L. Makinen, and S. A. Syed.
1994.
An endo-active proline-specific oligopeptidase from Treponema denticola ATCC 35405: evidence of hydrolysis of human bioactive peptides.
Infect. Immun.
62:4938-4947[Abstract/Free Full Text].
|
| 14.
|
McCartney-Francis, N.,
J. B. Allen,
D. E. Mizel,
J. E. Albina,
Q. W. Xie,
C. F. Nathan, and S. M. Wahl.
1993.
Suppression of arthritis by an inhibitor of nitric oxide synthase.
J. Exp. Med.
178:749-754[Abstract/Free Full Text].
|
| 15.
|
Moore, W. E. C.,
L. V. Holdeman,
E. P. Cato,
R. M. Smibert,
J. A. Burmeister, and R. R. Ranney.
1983.
Bacteriology of moderate (chronic) periodontitis in mature adult humans.
Infect. Immun.
42:510-515[Abstract/Free Full Text].
|
| 16.
|
Morrison, D. C., and D. M. Jacobs.
1976.
Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides.
Immunochemistry
13:813-818[Medline].
|
| 17.
|
Mundy, G. R.
1991.
Inflammatory mediators and the destruction of bone.
J. Periodontal Res.
26:213-217[Medline].
|
| 18.
|
Mundy, G. R.,
G. D. Roodman,
L. F. Bonewald,
T. Yoneda, and M. Sabatini.
1992.
Effect of TNF and lymphotoxin on bone cells, p. 483-498.
In
B. B. Aggarwal, and J. Vilcek (ed.), Tumor necrosis factors. Structure, function and mechanism of action. Marcel Dekker, Inc., New York, N.Y.
|
| 19.
|
Nathan, C.
1992.
Nitric oxide as a secretory product of mammalian cells.
FASEB J.
6:3051-3064[Abstract].
|
| 20.
|
Norgard, M. V.,
B. S. Riley,
J. A. Richardson, and J. D. Radolf.
1995.
Dermal inflammation elicited by synthetic analogs of Treponema pallidum and Borrelia burgdorferi lipoproteins.
Infect. Immun.
4:1507-1515.
|
| 21.
|
Offenbacher, S.,
W. A. Soskolne, and J. G. Collins.
1991.
Prostaglandins and other eicosanoids in gingival cervicular fluid as a markers of periodontal disease susceptibility and activity, p. 313-337.
In
N. W. Johnson (ed.), Risk markers for oral diseases: periodontal disease. Cambridge University Press, Cambridge, England.
|
| 22.
|
Page, R. C., and H. E. Schroeder.
1976.
Pathogenesis of inflammatory periodontal disease. A summary of current work.
Lab. Investig.
33:235-249.
|
| 23.
|
Page, R. C.
1991.
The role of inflammatory mediators in the pathogenesis of periodontal disease.
J. Periodontal Res.
26:230-242[Medline].
|
| 24.
|
Radin, N.
1981.
Extraction of tissue lipids with a solvent of low toxicity.
Methods Enzymol.
72:5-7[Medline].
|
| 25.
|
Radolph, J. D.,
L. L. Arndt,
D. R. Akins,
L. L. Curetty,
M. E. Levi,
Y. Shen,
L. S. Davis, and M. V. Norgard.
1994.
Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages.
J. Immunol.
154:2866-2877[Abstract].
|
| 26.
|
Ranney, R. R.
1977.
Pathogenesis of periodontal disease, p. 223-300.
In
B. Klavan, R. Genco, H. Loe, R. Page, I. Stern, J. Thorpe, and E. Barrington (ed.), International Conference on Research in the Biology of Periodontal Disease. The College of Dentistry, University of Illinois, Chicago, Ill.
|
| 27.
|
Riley, B. S.,
N. Oppenheimer-Marks,
E. J. Hansen,
J. D. Radolf, and M. V. Norgard.
1992.
Virulent Treponema pallidum activates human vascular endothelial cells.
J. Infect. Dis.
165:484-493[Medline].
|
| 28.
|
Rosen, G.,
R. Naor,
E. Rahamim,
R. Yishai, and M. N. Sela.
1995.
Proteases of Treponema denticola outer sheath and extracellular vesicles.
Infect. Immun.
63:3973-3979[Abstract].
|
| 29.
|
Schultz, C. P.,
V. Wolf,
R. Lange,
E. Mertens,
J. Wecke,
D. Naumann, and U. Zahringer.
1998.
Evidence for a new type of outer membrane lipid in oral spirochete Treponema denticola.
J. Biol. Chem.
273:15661-15666[Abstract/Free Full Text].
|
| 30.
|
Sela, M. N.,
A. Weinberg,
R. Borinsky,
S. C. Holt, and T. Dishon.
1988.
Inhibition of superoxide production in human polymorphonuclear leukocytes by treponemal factors.
Infect. Immun.
56:589-594[Abstract/Free Full Text].
|
| 31.
|
Sela, M. N.,
A. Bolotin,
R. Naor,
A. Weinberg, and G. Rosen.
1997.
Lipoproteins of Treponema denticola. Their effect on human polymorphonuclear neutrophils.
J. Periodontal Res.
32:455-466[Medline].
|
| 32.
|
Simonson, L. G.,
C. H. Goodman,
J. J. Bial, and H. E. Morton.
1988.
Quantitative relationship of Treponema denticola to severity of periodontal disease.
Infect. Immun.
56:726-728[Abstract/Free Full Text].
|
| 33.
|
Socransky, S. S., and A. D. Haffajee.
1992.
The bacterial etiology of destructive periodontal disease: current concepts.
J. Periodontol.
63:322-331[Medline].
|
| 34.
|
Stashenko, P.,
P. Fujiyoshi,
M. N. Obernesser,
L. Prostak,
A. D. Haffajee, and S. S. Socransky.
1991.
Levels of interleukin-1 beta in tissue from sites of active periodontal disease.
J. Clin. Periodontol.
18:548-554[Medline].
|
| 35.
|
Stashenko, P.,
J. J. Jundinski,
P. Fujiyoshi,
J. Rynar, and S. S. Socransky.
1991.
Tissue levels of bone-resorptive cytokines in periodontal disease.
J. Periodontol.
62:504-509[Medline].
|
| 36.
|
Uitto, V.-J.,
Y. M. Pan,
W. K. Leung,
H. Larjva,
R. P. Ellen,
B. B. Finlay, and B. C. McBride.
1995.
Cytopathic effects of Treponema denticola chymotrypsin-like proteinase on migrating and stratified epithelial cells.
Infect. Immun.
63:3401-3410[Abstract].
|
| 37.
|
Van Dyke, T. E.,
M. A. Lester, and L. Shapira.
1993.
The role of host response in periodontal disease progression: implications for future treatment strategies.
J. Periodontol.
64:792-806[Medline].
|
| 38.
|
Wahl, S. M.,
K. L. Hines,
T. Imamichi,
H. Tian,
S. Shepheard, and N. McCartney-Francis.
1994.
Regulation of chronic inflammation, p. 183-190.
In
R. Genco, S. Hamada, T. Lehner, J. McGhee, and S. Mergenhagen (ed.), Molecular pathogenesis of periodontal disease. ASM Press, Washington, D.C.
|
| 39.
|
Weinberg, J. B.,
D. L. Granger,
D. S. Pisetsky,
M. F. Seldin,
M. A. Misukonis,
S. N. Mason,
A. M. Pippen,
P. Ruiz,
E. R. Wood, and G. S. Gilkeson.
1994.
The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine.
J. Exp. Med.
179:651-660[Abstract/Free Full Text].
|
| 40.
|
Yotis, W. W.,
F. Macaluso, and C. Gopalsami.
1995.
Immunochemical features of a macromolecule of Treponema denticola.
J. Basic Microbiol.
35:255-268[Medline].
|
| 41.
|
Zhang, X., and D. C. Morrison.
1993.
Lipopolysaccharide-induced selective priming effects on tumor necrosis factor and nitric oxide production in mouse peritoneal macrophages.
J. Exp. Med.
177:511-516[Abstract/Free Full Text].
|
Infection and Immunity, March 1999, p. 1180-1186, Vol. 67, No. 3
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Nussbaum, G., Ben-Adi, S., Genzler, T., Sela, M., Rosen, G.
(2009). Involvement of Toll-Like Receptors 2 and 4 in the Innate Immune Response to Treponema denticola and Its Outer Sheath Components. Infect. Immun.
77: 3939-3947
[Abstract]
[Full Text]
-
Miyamoto, M., Ishihara, K., Okuda, K.
(2006). The Treponema denticola Surface Protease Dentilisin Degrades Interleukin-1{beta} (IL-1{beta}), IL-6, and Tumor Necrosis Factor Alpha. Infect. Immun.
74: 2462-2467
[Abstract]
[Full Text]
-
Lee, S.-H., Kim, K.-K., Rhyu, I.-C., Koh, S., Lee, D.-S., Choi, B.-K.
(2006). Phenol/water extract of Treponema socranskii subsp. socranskii as an antagonist of Toll-like receptor 4 signalling. Microbiology
152: 535-546
[Abstract]
[Full Text]
-
Hashimoto, M., Asai, Y., Ogawa, T.
(2003). Treponemal Phospholipids Inhibit Innate Immune Responses Induced by Pathogen-associated Molecular Patterns. J. Biol. Chem.
278: 44205-44213
[Abstract]
[Full Text]
-
Choi, B.-K., Lee, H. J., Kang, J. H., Jeong, G. J., Min, C. K., Yoo, Y.-J.
(2003). Induction of Osteoclastogenesis and Matrix Metalloproteinase Expression by the Lipooligosaccharide of Treponema denticola. Infect. Immun.
71: 226-233
[Abstract]
[Full Text]
-
Sela, M. N.
(2001). Role of Treponema Denticola in Periodontal Diseases. CROBM
12: 399-413
[Abstract]
[Full Text]
-
Schroder, N. W. J., Opitz, B., Lamping, N., Michelsen, K. S., Zahringer, U., Gobel, U. B., Schumann, R. R.
(2000). Involvement of Lipopolysaccharide Binding Protein, CD14, and Toll-Like Receptors in the Initiation of Innate Immune Responses by Treponema Glycolipids. J. Immunol.
165: 2683-2693
[Abstract]
[Full Text]
-
Schroder, N. W. J., Pfeil, D., Opitz, B., Michelsen, K. S., Amberger, J., Zahringer, U., Gobel, U. B., Schumann, R. R.
(2001). Activation of Mitogen-activated Protein Kinases p42/44, p38, and Stress-activated Protein Kinases in Myelo-monocytic Cells by Treponema Lipoteichoic Acid. J. Biol. Chem.
276: 9713-9719
[Abstract]
[Full Text]